ArticlePublic health challenges2026
Implications of Kenya's Enhanced Public Officers Medical Scheme on Equity in Strategic Purchasing and Progress Towards Universal Health Coverage.
Article in Public health challenges, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kenya transitioned its health financing from the National Health Insurance Fund (NHIF) to the Social Health Authority (SHA) in 2024. This model was designed to advance efficiency and equity, ultimately leading to universal health coverage (UHC). Shortly thereafter, the government introduced a parallel Enhanced Public Officers Medical Scheme Fund (POMSF), tailored to privilege public officers through dedicated funding and benefits. This article explores the implications of this targeted scheme on equity in strategic purchasing and the journey towards UHC. Methodology: The article is a policy perspective grounded on document review of legislation, regulations, government documents and grey literature. Evidence was identified through targeted searches of PubMed, Google Scholar and Kenyan sources. Analysis was guided by the Strategic Purchasing Resource Centre for Africa (SPARC) and RESYST strategic purchasing frameworks and organized across governance, revenue mobilization, risk pooling, benefit design, provider contracting, provider payment, access protocols, financial protection and accountability. Comparative evidence from civil-servant and segmented insurance arrangements in Thailand, Tanzania and Indonesia was used. Findings: SHA is designed to support population coverage, cross-subsidization, standardized entitlements and primary healthcare-led access. POMSF, although administered through SHA, relies on ring-fenced public financing, a scheme-specific governance structure, enhanced benefits, separate contractual arrangements, negotiated tariffs and flexible access pathways for public officers. These features may improve financial protection and service responsiveness for beneficiaries but risk-fragmenting pools, weakening redistribution, creating unequal entitlements and generating competing provider incentives. Conclusions: POMSF is not inherently incompatible with UHC, but its equity effects depend on how it is financed, governed and linked to SHA. Kenya should establish transparent financial links, common purchasing standards, harmonized tariffs and referral rules, integrated data and accountability systems, and periodic equity review. Without these safeguards, POMSF may entrench a two-tier system, weaken solidarity within health financing and Kenya's movement towards equitable UHC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.